[Group A beta-hemolytic streptococcal toxic shock]

Area of Science:

• Infectious Diseases
• Bacteriology
• Clinical Medicine

Background:

• Invasive group A beta-hemolytic Streptococcus (Streptococcus pyogenes) infections, including toxic shock syndrome (TSS), show increasing incidence.
• Skin and mucous membranes are common entry points for Streptococcus pyogenes.
• Toxic shock syndrome can be a rare complication of pharyngitis.

Observation:

• The association between varicella (chickenpox) and nonsteroidal anti-inflammatory drug (NSAID) use with necrotizing fasciitis caused by Streptococcus pyogenes is debated.
• Some studies suggest NSAID use may be contraindicated in varicella due to potential risks.
• A clinical case involved a 12-year-old adolescent diagnosed with mononucleosis, treated with ibuprofen, who later developed severe streptococcal toxic shock syndrome.

Findings:

• The adolescent patient presented with rhabdomyolysis, hepatitis, cellulitis, arthritis, and pleural effusion secondary to Streptococcus pyogenes infection.
• Treatment involved penicillin G and clindamycin.
• This case underscores the potential severity and complex presentation of invasive Streptococcus pyogenes infections.

Implications:

• The case raises questions about the potential role of prior viral infections and NSAID use in the development of severe invasive Streptococcus pyogenes disease.
• Highlights the importance of considering invasive bacterial infections in patients with severe symptoms following viral illnesses, especially after NSAID exposure.
• Emphasizes the need for continued vigilance and research into risk factors and management of invasive group A Streptococcus infections.